We are now focused on executing this pivotal trial to bring a convenient, oral weight-loss option to patients globally." Beyond its lead asset, MindRank has secured three investigational new drug clearances across China and the US and nominated five further preclinical candidates
Michaels AD, Hunter Mehaffey J, Brenton W, et al
The translational gap remains large (no PCOSspecific trials yet), but the mechanistic rationale is compelling
Glucagon-like peptide-1 (GLP-1) and its receptor (GLP-1R) have shown neuroprotective effects
The bioavailability difference only matters for oral, nasal, and topical routes of administration
Personalized medication plan 100% online visit and checkout Shipped straight to your door Free GLP-1 shot tracking app *In clinical trials studying Wegovy (2.4 mg), the average weight loss was 15% and 20%, respectively, when paired with diet and exercise (compared to 2.4% and 3.1% with diet and exercise alone)